NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

403 hedge funds and large institutions have $8.59B invested in Neurocrine Biosciences in 2020 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 145 increasing their positions, 150 reducing their positions, and 73 closing their positions.

Holders
403
Holders Change
-14
Holders Change %
-3.36%
% of All Funds
7.15%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.09%
New
63
Increased
145
Reduced
150
Closed
73
Calls
$39.8M
Puts
$116M
Net Calls
-$76.5M
Net Calls Change
+$18.6M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$878M
2
Citadel Advisors
2
Citadel Advisors
Florida
$110M
3
EVM
3
Eaton Vance Management
Massachusetts
$50.7M
4
PAMU
4
Pictet Asset Management (UK)
United Kingdom
$163M
5
PA
5
Perceptive Advisors
New York
$182M

Top Sellers

1
Capital International Investors
1
Capital International Investors
California
$327M
2
Macquarie Group
2
Macquarie Group
Australia
$22.2M
3
HM
3
HealthCor Management
New York
$21.7M
4
Invesco
4
Invesco
Georgia
$104M
5
AllianceBernstein
5
AllianceBernstein
Tennessee
$5.59M
Name Market Value Shares Shares
Change 		Shares
Change %
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$878M 9,161,141 +2,612,748 +40%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$801M 8,357,078 -346,668 -4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$799M 8,337,265 +175,732 +2%
BlackRock
4
BlackRock
New York
$671M 6,997,795 +182,933 +3%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$601M 6,271,730 -150,008 -2%
Capital International Investors
6
Capital International Investors
California
$327M 3,412,649 -862,827 -20%
BG
7
Bellevue Group
Switzerland
$326M 3,396,651 +99,200 +3%
State Street
8
State Street
Massachusetts
$237M 2,477,331 +199,942 +9%
PA
9
Perceptive Advisors
New York
$182M 1,899,215 +350,500 +23%
Renaissance Technologies
10
Renaissance Technologies
New York
$173M 1,807,191 -342,273 -16%
PAMU
11
Pictet Asset Management (UK)
United Kingdom
$163M 1,696,990 +366,467 +28%
RSCM
12
Rock Springs Capital Management
Maryland
$151M 1,575,000 +109,500 +7%
O
13
OrbiMed
New York
$125M 1,301,715 – –
Goldman Sachs
14
Goldman Sachs
New York
$117M 1,217,765 +328,594 +37%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$112M 1,171,682 +58,975 +5%
Citadel Advisors
16
Citadel Advisors
Florida
$110M 1,147,507 +836,009 +268%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$108M 1,125,610 +59,008 +6%
DCP
18
DSM Capital Partners
Florida
$107M 1,116,380 +279,614 +33%
Invesco
19
Invesco
Georgia
$104M 1,083,141 -650,332 -38%
JPMorgan Chase & Co
20
JPMorgan Chase & Co
New York
$91.4M 953,263 +187,785 +25%
Franklin Resources
21
Franklin Resources
California
$85.8M 894,870 -635,290 -42%
CAM
22
Congress Asset Management
Massachusetts
$72.9M 760,941 -6,709 -0.9%
Norges Bank
23
Norges Bank
Norway
$67.8M 707,402 -31,949 -4%
Brown Advisory
24
Brown Advisory
Maryland
$66.9M 697,730 +54,588 +8%
BBA
25
Baker Bros. Advisors
New York
$64.9M 676,975 – –
1
2 3 4 5